Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside.
Alborghetti, Marika
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside. [electronic resource] - Current neuropharmacology 2019 - 861-873 p. digital
Publication Type: Journal Article; Review
1875-6190
10.2174/1570159X16666180830100754 doi
Alanine--analogs & derivatives
Antiparkinson Agents--therapeutic use
Benzylamines--therapeutic use
Dopamine Agents--therapeutic use
Humans
Indans--therapeutic use
Levodopa--therapeutic use
Male
Monoamine Oxidase Inhibitors--therapeutic use
Parkinson Disease--drug therapy
Selegiline--therapeutic use
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside. [electronic resource] - Current neuropharmacology 2019 - 861-873 p. digital
Publication Type: Journal Article; Review
1875-6190
10.2174/1570159X16666180830100754 doi
Alanine--analogs & derivatives
Antiparkinson Agents--therapeutic use
Benzylamines--therapeutic use
Dopamine Agents--therapeutic use
Humans
Indans--therapeutic use
Levodopa--therapeutic use
Male
Monoamine Oxidase Inhibitors--therapeutic use
Parkinson Disease--drug therapy
Selegiline--therapeutic use